Vγ9Vδ2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas

被引：0
|
作者：
Francoise Bouet-Toussaint
Florian Cabillic
Olivier Toutirais
Matthieu Le Gallo
Cécile Thomas de la Pintière
Pascale Daniel
Noëlle Genetet
Bernard Meunier
Eric Dupont-Bierre
Karim Boudjema
Véronique Catros
机构：
[1] UPRES EA 3891,Laboratoire de Cytogénétique et Biologie Cellulaire
[2] Faculté de Médecine de Rennes,Département de Chirurgie Viscérale
[3] CHU de Rennes,undefined
[4] CHU de Rennes,undefined
来源：
Cancer Immunology, Immunotherapy | 2008年 / 57卷
关键词：
Human; T cells; Cytotoxic; Cell activation; Tumor immunity; T Cell receptors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：531 / 539
页数：8
相关论文
共 50 条
  • [31] Prevention of Vγ9Vδ2 T cell activation by a Vγ9Vδ2 TCR nanobody (vol 198, pg 308, 2017)
    de Bruin, R. C. G.
    Stam, A. G. M.
    Vangone, A.
    Henegouwen, P. M. P. van Bergen En
    Verheul, H. M. W.
    Sebestyen, Z.
    Kuball, J.
    Bonvin, A. M. J. J.
    de Gruijl, T. D.
    van der Vliet, H. J.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (09): : 3759 - 3759
  • [32] IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human Vγ9Vδ2 T Cells for Adoptive Immunotherapy
    Thedrez, Aurelie
    Harly, Christelle
    Morice, Alexis
    Salot, Samuel
    Bonneville, Marc
    Scotet, Emmanuel
    JOURNAL OF IMMUNOLOGY, 2009, 182 (06): : 3423 - 3431
  • [33] Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire
    Dimova, Tanya
    Brouwer, Margreet
    Gosselin, Francoise
    Tassignon, Joel
    Leo, Oberdan
    Donner, Catherine
    Marchant, Arnaud
    Vermijlen, David
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (06) : E556 - E565
  • [34] An Update on the Molecular Basis of Phosphoantigen Recognition by Vγ9Vδ2 T Cells
    Herrmann, Thomas
    Fichtner, Alina Suzann
    Karunakaran, Mohindar Murugesh
    CELLS, 2020, 9 (06) : 1 - 26
  • [35] Recognition of nonpeptide antigens by human Vγ9Vδ2 T cells requires contact with cells of human origin
    Green, AE
    Lissina, A
    Hutchinson, SL
    Hewitt, RE
    Temple, B
    James, D
    Boulter, JM
    Price, DA
    Sewell, AK
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (03): : 472 - 482
  • [36] Vγ9Vδ2 T cell response to colon carcinoma cells
    Corvaisier, M
    Moreau-Aubry, A
    Diez, E
    Bennouna, J
    Mosnier, JF
    Scotet, E
    Bonneville, M
    Jotereau, F
    JOURNAL OF IMMUNOLOGY, 2005, 175 (08): : 5481 - 5488
  • [37] Human Vγ9Vδ2 T cells: From signals to functions
    Nedellec, Steven
    Bonneville, Marc
    Scotet, Emmanuel
    SEMINARS IN IMMUNOLOGY, 2010, 22 (04) : 199 - 206
  • [38] Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy
    Werter, Inge M.
    Schneiders, Famke L.
    Scotet, Emmanuel
    Verheul, Henk M. W.
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    ONCOIMMUNOLOGY, 2014, 3 (09)
  • [39] Expansion of autologous human Vγ9Vδ2 T cells ex vivo: potential for adoptive T cell therapy of prostate cancer
    Roberts, A.
    Serrano, M.
    Vantourout, P.
    Dieli, F.
    Pandha, H.
    Hayday, A. C.
    IMMUNOLOGY, 2010, 131 : 119 - 119
  • [40] Expansion of Autologous Human Vγ9Vδ2 T Cells Ex Vivo: Potential for Adoptive T Cell Therapy of Prostate Cancer
    Roberts, Andrew
    Serrano, Maria
    Binda, Elisa
    Vantourout, Pierre
    Pandha, Hardev
    Hayday, Adrian C.
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 864 - 864
12345